Glaceum 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
vutiglabridin (HSG4112) / Glaceum
NCT05197556: A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients

Completed
2
81
RoW
HSG4112, 2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo
Glaceum, Gangnam Severance Hospital, Seoul National University Bundang Hospital, Korea University Anam Hospital, Seoul National University Hospital, SMG-SNU Boramae Medical Center
Obesity
12/22
04/23
NCT06329141: A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Recruiting
2
90
RoW
Vutiglabridin, HSG4112, 2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo
Glaceum, The Catholic University of Korea, Kyunghee University Medical Center, Korea University Guro Hospital, Samsung Medical Center, Severance Hospital, Inje University, Hallym University Medical Center, The Catholic University of Korea Uijeongbu St.Marys Hostpial
Parkinson Disease
12/25
06/26
NCT06845553: A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients

Not yet recruiting
2
60
NA
Vutiglabridin, HSG4112,2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo
Glaceum, Seoul National University Hospital, Bundang Seoul National University Hospital
Knee Osteoarthritis (Knee OA)
07/26
12/26
NCT05310032: A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses

Completed
1
36
RoW
HSG4112, 2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo
Glaceum, Seoul National University Hospital
Obesity
12/22
03/23
HGR4113 / Glaceum
NCT05642377: A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects

Recruiting
1
40
RoW
HGR4113, Placebo
Glaceum, Seoul National University Hospital
Diabetes Mellitus, Type 2
07/24
01/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
vutiglabridin (HSG4112) / Glaceum
NCT05197556: A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients

Completed
2
81
RoW
HSG4112, 2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo
Glaceum, Gangnam Severance Hospital, Seoul National University Bundang Hospital, Korea University Anam Hospital, Seoul National University Hospital, SMG-SNU Boramae Medical Center
Obesity
12/22
04/23
NCT06329141: A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Recruiting
2
90
RoW
Vutiglabridin, HSG4112, 2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo
Glaceum, The Catholic University of Korea, Kyunghee University Medical Center, Korea University Guro Hospital, Samsung Medical Center, Severance Hospital, Inje University, Hallym University Medical Center, The Catholic University of Korea Uijeongbu St.Marys Hostpial
Parkinson Disease
12/25
06/26
NCT06845553: A Study to Assess the Efficacy and Safety of Vutiglabridin in Knee Osteoarthritis Patients

Not yet recruiting
2
60
NA
Vutiglabridin, HSG4112,2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo
Glaceum, Seoul National University Hospital, Bundang Seoul National University Hospital
Knee Osteoarthritis (Knee OA)
07/26
12/26
NCT05310032: A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HSG4112 in High Doses

Completed
1
36
RoW
HSG4112, 2-(8,8 dimethyl 2,3,4,8,9,10 hexahydropyrano[2,3 f]chromen 3 yl) 5 ethoxyphenol, Placebo
Glaceum, Seoul National University Hospital
Obesity
12/22
03/23
HGR4113 / Glaceum
NCT05642377: A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects

Recruiting
1
40
RoW
HGR4113, Placebo
Glaceum, Seoul National University Hospital
Diabetes Mellitus, Type 2
07/24
01/25

Download Options